Sun, Apr 20, 2014, 4:03 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • Bio_guyo Bio_guyo Aug 24, 2012 10:08 AM Flag

    Change in fundamentals yet no change in share price

    Interesting that one of the leading competitors to Incivek dominance of the HepC market, BMY, has had their lead next-generation treatment regimen fail, and yet VRTX share price hasn't responded accordingly. It's one of those cases where the fundamentals for VRTX just improved considerably without the market acknowledging it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
64.17-0.22(-0.34%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.